Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo-Reference-Cited by-同舟云学术

Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo

Published:2016-09-29 Issue:9 Volume:11 Page:e0163209
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nirvanappa Anilkumar C.,Mohan Chakrabhavi Dhananjaya,Rangappa Shobith,Ananda Hanumappa,Sukhorukov Alexey Yu,Shanmugam Muthu K.,Sundaram Mahalingam S.,Nayaka Siddaiah Chandra,Girish Kesturu S.,Chinnathambi Arunachalam,Zayed M. E.,Alharbi Sulaiman Ali,Sethi Gautam,Basappa ,Rangappa Kanchugarakoppal S.

Funder

Department of Science and Techology

Department of Science and Technology

University Grants Commission

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon;H Laroui;PLoS One,2012

2. Carbon monoxide attenuates dextran sulfate sodium-induced colitis via inhibition of GSK-3beta signaling;MJ Uddin;Oxid Med Cell Longev,2013

3. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement;A Ekbom;Lancet,1990